Novo Nordisk of North America, Inc., Novo Nordisk Pharmaceuticals, Inc., and Novo Nordisk, A/s v. Genentech, Inc.

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• the Federal Circuit stated that determining whether a patent specification was enabling would require “resolution of factual questions”
• “claim 2 covers only a method of directly expressing human growth hormone and does not encompass a cleavable fusion expression process”
• “[n]either the public interest nor equity favors grant of an injunction against one who does not infringe”

Source: CourtListener parenthetical corpus (CC0).